Expiring federal contract · order under a contract vehicle
36C24626N0099 — Biomerieux INC
Department of Veterans Affairs
- Contract / PIID
- 36C24626N0099
- Incumbent
- Biomerieux INC
- Incumbent UEI
- HCNVCMEG9NL6
- Current end date
- December 2, 2026
- Potential total value
- $161,694
- Obligated
- $161,694
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 — LABORATORY EQUIPMENT AND SUPPLIES
- Set-aside
- Not stated
- Start date
- December 3, 2025
- Place of performance
- UT
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
BLOOD CULTURE LABS
Likely rebid window (estimate)
- Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
- RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)
In the final months before the current end date.
This is an order under contract vehicle 36C24626D0002. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 1 recorded change to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Veterans Affairs (NAICS 325413)
- 36C24126F0009 — Fisher Scientific Company L.L.C. · ends November 23, 2026 · $349K
- 36C24426N0199 — Beckman Coulter, INC · ends November 30, 2026 · $129K
- 36C24426N0200 — Beckman Coulter, INC · ends November 30, 2026 · $115K
- 36C24426N0201 — Beckman Coulter, INC · ends November 30, 2026 · $104K
- 36C24426N0202 — Beckman Coulter, INC · ends November 30, 2026 · $110K
- 36C24526P0090 — Cepheid · ends November 30, 2026 · $215K
- 36C25026N0722 — Sebia, INC. · ends November 30, 2026 · $103K
- 36C25726N0059 — Qiagen, LLC · ends November 30, 2026 · $107K
- 36C25926N0155 — Abbott Molecular INC. · ends November 30, 2026 · $350K
- 36C26024P0112 — Biofire Diagnostics LLC · ends November 30, 2026 · $644K